| Literature DB >> 35725752 |
Kenichiro Okimoto1, Tomoaki Matsumura2, Daisuke Maruoka2,3, Akane Kurosugi2, Wataru Shiratori2, Ariki Nagashima2, Tsubasa Ishikawa2, Tatsuya Kaneko2, Kengo Kanayama2, Naoki Akizue2, Yuki Ohta2, Takashi Taida2, Keiko Saito2, Jun Kato2, Naoya Kato2.
Abstract
This pilot study aimed to investigate the utility of texture and color enhancement imaging (TXI) with magnified endoscopy (ME) for the preoperative diagnosis of superficial nonampullary duodenal epithelial tumors (SNADETs). We prospectively evaluated 12 SNADETs. The visibility for ME-TXI, ME with indigo carmine (ICME)-white-light imaging (WLI), ICME-TXI compared to ME-NBI (narrow-band imaging) was scored (+ 2 to - 2 ME-NBI was set as score 0) by 3 experts. Scores + 2 and + 1 were defined as improved visibility. The intra-observer and interobserver agreement for improved visibility of surface structure (SS) was evaluated. Sensitivity, specificity, and positive predictive value (PPV) for Vienna Classification (VCL) C4/5 associated with the preoperative diagnosis of ICME-TXI were analyzed. The SS visibility score of ICME-TXI was significantly higher than that of ME-NBI, ME-TXI, and ICME-WLI (P < 0.001 respectively). The kappa coefficients of reliability for intra-observer and interobserver agreement for the SS visibility improvement with ICME-TXI were 0.96, 1.00, 1.00 and 0.70, 0.96, 0.96 respectively. All endoscopists preferred ICME-TXI for visualizing SS mostly for all lesions. The sensitivity, specificity, and PPV (%) of ICME-TXI for VCL C4/5 were 80, 66.7, and 63.2, respectively. ICME-TXI facilitates the visibility of the SS of SNADETs and may contribute to their preoperative diagnosis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35725752 PMCID: PMC9209444 DOI: 10.1038/s41598-022-14476-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Characteristics of the participants and lesions.
| All patients | |
|---|---|
| (n = 11) | |
| Age (years), median (range) | 69 (37–80) |
| Male/female | 5/6 |
VCL Vienna classification, CSP cold snare polypectomy, UEMR underwater endoscopic mucosal resection.
Figure 1Representative cases of SNADETs for each modality. SNADET, Superficial nonampullary duodenal epithelial tumors; ME-WLI, magnified endoscopy with white-light imaging, ME-NBI magnified endoscopy with narrow-band imaging, ME-TXI magnified endoscopy with texture and color enhancement imaging, ICME-WLI indigo carmine dye with ME-WLI, ICME-TXI indigocarmine dye with ME-TXI, VCL Vienna classification, IMC intramucosal carcinoma. (a) 13 mm, IIa, pathological diagnosis of VCL C3. A. ME-NBI. B. ME-TXI. C. ICME-WLI. D. ICME-TXI. Open-loop was observed. (b) 10 mm, IIa, pathological diagnosis of VCL C4/5 (IMC). A. ME-NBI. B. ME-TXI. C. ICME-WLI. D. ICME-TXI. Closed-loop was observed.
Figure 2The mean visibility scores (described mean ± SD) for each modality. The mean visibility score of ME-NBI was set as score 0. SD standard deviation, ME-WLI magnified endoscopy with white-light imaging, ME-NBI magnified endoscopy with narrow-band imaging, ME-TXI magnified endoscopy with texture and color enhancement imaging, ICME-WLI indigo carmine dye with ME-WLI, ICME-TXI indigocarmine dye with ME-TXI. (a) Mean visibility score for surface structure. Mean visibility scores for ME-TXI, ICME-WLI, ICME-TXI were − 0.08 ± 0.81, 0.22 ± 0.87, 1.58 ± 0.60, respectively. (b) Mean visibility score for blood vessels. Mean visibility score for ME-TXI, ICME-WLI, ICME-TXI were − 0.78 ± 0.80, − 1.19 ± 0.71, − 0.58 ± 0.55, respectively.
P value of visibility scores of SNADETs in ME-TXI, ICME-WLI, and ICME-TXI compared to ME-NBI.
| ME-NBI vs ME-TXI | ME-NBI vs ICME-WLI | ME-NBI vs ICME-TXI | ME-TXI vs ICME-WLI | ME-TXI vs ICME-TXI | ICME-WLI vs ICME-TXI |
|---|---|---|---|---|---|
| (a) | |||||
| 1.000 | 1.000 | < 0.001 | 1.000 | < 0.001 | < 0.001 |
| (b) | |||||
| 0.001 | < 0.001 | 0.028 | 0.082 | 1.000 | 0.003 |
The ME-NBI was set as score 0.
P value was calculated using Friedman’s test with Bonferroni correction.
SNADETs superficial nonampullary duodenal epithelial tumors, ME-WLI magnified endoscopy with white-light imaging, ME-NBI magnified endoscopy with narrow-band imaging, ME-TXI magnified endoscopy with texture and color enhancement imaging, ICME-WLI indigo carmine dye with ME-WLI, ICME-TXI, indigocarmine dye with ME-TXI.